You can buy or sell Intrexon and other stocks, options, ETFs, and crypto commission-free!
Intrexon Corporation Common Stock, also called Intrexon, is a biotechnology company, which engages in the research and development of synthetic biology technologies. It focuses on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. Read More The product pipeline includes Isobutanol, Isobutyraldehyde, Farnesene, and Isoprene. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
52 Week High
52 Week Low
NYSE:XON - Stock Price, News, & Analysis for Intrexon
Intrexon Corporation operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabl...
The Motley FoolMar 5
Here's What Caused Intrexon's 21% Rally Today
What happened After value stock investor Bill Miller tweeted positively about the company following its steep post-earnings drop, shares in Intrexon (NASDAQ:XON) jumped 21% at 3:30 p.m. EST on Tuesday. So what Intrexon's shares have been beaten up following its disclosure that auditors are including language regarding its ability to remain a going concern in its annual 10-K filing with the Securities and Exchange Commission. The doubt regarding Intrexon's future stems from decelerating revenue because o...
Yahoo FinanceMar 5
Market Trends Toward New Normal in Ritchie Bros. Auctioneers, Empire State Realty Trust, Synergy Resources, IQVIA, Intrexon, and Denbury Resources — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, March 05, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Ritchie Bros.
Expected May 9, After Hours